Mergers & Acquisitions ·
Crinetics Pharmaceuticals, Inc. entered into non-compete agreements with key employees, including CEO R. Scott…
CRNXCrinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. entered into non-compete agreements with key employees, including CEO R. Scott Struthers, Ph.D., CFO Tobin Schilke, CSO Stephen Betz, Ph.D., and CCO Isabel Kalofonos, following its merger agreement with Vertex Pharmaceuticals Incorporated. The restricted parties will be subject to one-year non-compete restrictions for a period of one year following the merger closing date. Tobin Schilke, Stephen Betz, and Isabel Kalofonos will receive cash payments of $140,000, $30,000, and $30,000, respectively, upon the merger closing. Crinetics Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing therapeutic solutions for rare diseases.